Skip to main content

Table 2 Regression analysis results of risk factors for fragility fracture

From: A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures

 

Wald Z

P

OR (95% CI)

Total cholesterol (mmol/l)

9.234

0.003

0.483 (0.301–0.768)

Alkaline phosphatase (U/L)

12.576

0.001

1.004 (0.989–1.010)

Correct calcium (mmol/l)

5.487

0.018

7.986 (2.402–46.897)

Parathyroid hormone (pg/ml)

9.905

0.002

0.912 (0.873–0.958)

  1. (FF group: n=44; CG group: n=192)